Introducing STAT’s Biotech Q2 Scorecard, our emoji-enabled means of tracking 12 make-or-break events expected over the next three months.
When each clinical trial or FDA decision crosses the wires, we’ll add in the appropriate rocket ship, grimace face, bulging bicep or broken heart — whatever captures the mood.
Read on for brief explanations of what we’re watching for from each company.
About the Author Reprints
Is this chart uptodate as of 5/22?
This page is not working. https://www.statnews.com/2017/10/03/q4-biotech-scorecard/?utm_campaign=trendmd-internal
The new Biotech Scorecard: 10 make-or-break industry events for the fourth quarter
STAT
Thanks for the heads up. We fixed the problem and that link is working now.
Pat Skerrett
STAT